会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • USING BASE-STATION LOCATION TO ASSIST MOBILE-DEVICE SYSTEM ACQUISITION
    • 使用基站位置来协助移动设备系统采集
    • WO2009158339A1
    • 2009-12-30
    • PCT/US2009/048262
    • 2009-06-23
    • CLEAR WIRELESS LLCLAN, Wei-MingTALAULICAR, Abhinay
    • LAN, Wei-MingTALAULICAR, Abhinay
    • H04W48/18
    • H04W48/18
    • Methods and systems are provided for using base-station location to assist mobile- device system acquisition. A mobile station, which stores a network identifier, selects a carrier frequency. The mobile station receives, from a base station on a first carrier frequency, geographic coordinates of the base station and a base-station network identifier, and determines whether the base-station network identifier matches the mobile-station network identifier. If the base-station network identifier matches the mobile-station network identifier, the mobile station will scan the indicated home frequency bands and will connect to one of the home frequencies, and if the base-station network identifier does not match the mobile-station network identifier, the geographic coordinates of the base station are used to identify a market area and a most-preferred carrier frequency is selected from the identified market area.
    • 提供了使用基站位置来辅助移动设备系统采集的方法和系统。 存储网络标识符的移动站选择载波频率。 移动站从基站在第一载波频率上接收基站的地理坐标和基站网络标识符,并且确定基站网络标识符是否与移动站网络标识符匹配。 如果基站网络标识符与移动台网络标识符匹配,则移动台将扫描指示的归属频带并连接到家庭频率中的一个,并且如果基站网络标识符与移动台不匹配 网络标识符,基站的地理坐标用于识别市场区域,并且从所识别的市场区域中选择最优选的载波频率。
    • 9. 发明申请
    • NARC10 AND NARC16, PROGRAMMED CELL DEATH-ASSOCIATED MOLECULES AND USES THEREOF
    • NARC10和NARC16,编程性细胞死亡相关分子及其用途
    • WO2002081516A2
    • 2002-10-17
    • PCT/US2002/001098
    • 2002-01-16
    • MILLENNIUM PHARMACEUTICALS, INC.CHIANG, Lillian, Wei-Ming
    • CHIANG, Lillian, Wei-Ming
    • C07K14/47
    • C07K14/4747A01K2217/05
    • Novel programmed cell death-like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length programmed cell death-related polypeptides, the invention further provides isolated programmed cell death-related fusion proteins, antigenic peptides, and anti-programmed cell death-related antibodies. The invention also provides programmed cell death-related nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a programmed cell death-related gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilising compositions of the invention are also provided.
    • 公开了新的程序性细胞死亡样多肽,蛋白质和核酸分子。 除了分离的全长程序性细胞死亡相关多肽之外,本发明还提供了分离的程序性细胞死亡相关融合蛋白,抗原肽和抗程序性细胞死亡相关抗体。 本发明还提供了程序性细胞死亡相关核酸分子,含有本发明的核酸分子的重组表达载体,已经引入了表达载体的宿主细胞和其中程序性细胞死亡相关基因具有的非人类转基因动物 被引入或中断。 还提供了利用本发明组合物的诊断,筛选和治疗方法。